NanoEcho
0.15
SEK
-5.06 %
NANECH
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Be the first to follow this company
-5.06%
+16.46%
-55.82%
-
-
-
-
-
-16.62%
NanoEcho is active in healthcare, with a main focus in rectal cancer diagnostics. The company is active in the clinical stage, where a new diagnostic method is being developed to determine whether early rectal cancer has spread to nearby lymph nodes. The method aims to provide a correct diagnosis and individualized treatment. NanoEcho was founded in 2013 and has its headquarters in Lund.
Read moreMarket cap
26.07M SEK
Turnover
42.18K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Financial calendar
13.2
2025
Annual report '24
30.4
2025
Interim report Q1'25
21.8
2025
Interim report Q2'25